Article

General Anesthetic Binding to Neuronal alpha 4 beta 2 Nicotinic Acetylcholine Receptor and Its Effects on Global Dynamics

Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
The Journal of Physical Chemistry B (Impact Factor: 3.38). 09/2009; 113(37):12581-9. DOI: 10.1021/jp9039513
Source: PubMed

ABSTRACT The neuronal alpha4beta2 nicotinic acetylcholine receptor (nAChR) is a target for general anesthetics. Currently available experimental structural information is inadequate to understand where anesthetics bind and how they modulate the receptor motions essential to function. Using our published open-channel structure model of alpha4beta2 nAChR, we identified and evaluated six amphiphilic interaction sites for the volatile anesthetic halothane via flexible ligand docking and subsequent 20-ns molecular dynamics simulations. Halothane binding energies ranged from -6.8 to -2.4 kcal/mol. The primary binding sites were located at the interface of extracellular and transmembrane domains, where halothane perturbed conformations of, and widened the gap among, the Cys loop, the beta1-beta2 loop, and the TM2-TM3 linker. The halothane with the highest binding affinity at the interface between the alpha4 and beta2 subunits altered interactions between the protein and nearby lipids by competing for hydrogen bonds. Gaussian network model analyses of the alpha4beta2 nAChR structures at the end of 20-ns simulations in the absence or presence of halothane revealed profound changes in protein residue mobility. The concerted motions critical to protein function were also perturbed considerably. Halothane's effect on protein dynamics was not confined to the residues adjacent to the binding sites, indicating an action on a more global scale.

0 Followers
 · 
77 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This thesis describes the use of peptide backbone amide-to-ester mutations to study the structure and function of ligand-gated ion channels. The research described herein has been done on the muscle nicotinic acetylcholine receptor, a prototypical ligand-gated ion channel in the cys-loop superfamily. Backbone mutagenesis in these proteins provides insight into specific intermolecular interactions that are critical to function, as well as answering more fundamental questions about the role of the peptide backbone in long-range conformational changes in these allosteric receptors. Chapter 2 describes the identification of a key hydrogen bond near the binding site that is involved in the gating pathway. We found that the backbone N-H of a loop C residue makes a hydrogen bond to an anionic side chain of the complementary subunit upon agonist binding. The hydrogen bonding partner is not the residue predicted by structural data, but instead an aspartate that was originally believed to participate directly in agonist binding. In chapter 3 we consider the involvement of the peptide backbone in the binding-induced conformational changes that lead to channel gating. Single backbone mutations in the β-sheet-rich extracellular domain were well tolerated, whereas two proximal backbone mutations led to nonfunctional receptors. These results support a model in which backbone movements in the outer β-sheet are important for receptor function. Chapter 4 describes a new method - elucidating long-range functional coupling in allosteric receptors (ELFCAR) - that should be broadly applicable to determining functional roles of residues in allosteric receptors. Chapters 5 and 6 describe electrophysiological and computational investigations into the role of amide-to-ester mutations in the aromatic binding box of the nicotinic receptor. Echoing the results of chapter 3, these mutations largely reveal an overall tolerance of backbone mutations in the binding site. Finally, in chapter 7, we explore the use of ester and N-methyl backbone modifications to uncover the role of conformational changes at an unusual vicinal disulfide bond near the tip of the C-loop. Using ab initio calculations, we demonstrate that N-methylation and esterification of this ring structure in model peptides dramatically impacts its cis-trans conformational preferences.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the structural components underlying differences in affinity, potency, and selectivity of varenicline for several human (h) nicotinic acetylcholine receptors (nAChRs), functional and structural experiments were performed. The Ca(2+) influx results established that: (a) varenicline activates (μM range) nAChR subtypes with the following rank sequence: hα7>hα4β4>hα4β2>hα3β4≫>hα1β1γδ; (b) varenicline binds to nAChR subtypes with the following affinity order (nM range): hα4β2~hα4β4>hα3β4>hα7≫>Torpedo α1β1γδ. The molecular docking results indicating that more hydrogen bond interactions are apparent for α4-containing nAChRs in comparison to other nAChRs may explain the observed higher affinity; and that (c) varenicline is a full agonist at hα7 (101%) and hα4β4 (93%), and a partial agonist at hα4β2 (20%) and hα3β4 (45%), relative to (±)-epibatidine. The allosteric sites found at the extracellular domain (EXD) of hα3β4 and hα4β2 nAChRs could explain the partial agonistic activity of varenicline on these nAChR subtypes. Molecular dynamics simulations show that the interaction of varenicline to each allosteric site decreases the capping of Loop C at the hα4β2 nAChR, suggesting that these allosteric interactions limit the initial step in the gating process. In conclusion, we propose that in addition to hα4β2 nAChRs, hα4β4 nAChRs can be considered as potential targets for the clinical activity of varenicline, and that the allosteric interactions at the hα3β4- and hα4β2-EXDs are alternative mechanisms underlying partial agonism at these nAChRs. Copyright © 2014 Elsevier B.V. All rights reserved.
    Biochimica et Biophysica Acta (BBA) - Biomembranes 12/2014; 1848(2). DOI:10.1016/j.bbamem.2014.11.003 · 3.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pentameric ligand-gated ion channels (pLGICs) conduct upon the binding of an agonist and are fundamental to neurotransmission. New insights into the complex mechanisms underlying pLGIC gating, ion selectivity and modulation have recently been gained via a series of crystal structures in prokaryotes and Caenorhabditis elegans, as well as computational studies relying on these structures. Here, we review contributions from a variety of computational approaches, including normal-mode analysis, automated docking and fully atomistic molecular dynamics simulation. Examples from our own research, particularly concerning interactions with general anaesthetics and lipids, are used to illustrate predictive results complementary to crystallographic studies.
    Molecular Simulation 04/2014; 40(10-11). DOI:10.1080/08927022.2014.896462 · 1.12 Impact Factor

Preview

Download
0 Downloads
Available from